Tag: Vaccines
Moderna Says Updated COVID-19 Vaccine Shields Against Highly Mutated New Variant
Scientists found the variant appears to be less concerning than initially thought, with data showing it is 60 percent less infectious than XBB.1.5 variants
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
Recommendations Updated for Flu Vaccine in Children
Providers may administer whichever product is appropriate and readily available to achieve the highest possible coverage
Teens May Have Missed Vaccinations During COVID-19 Pandemic
Among adolescents born in 2008, vaccination coverage by age 14 years continued to lag versus earlier birth cohorts
Poll: Only Half of Older Adults Have Heard of New RSV Vaccine
However, poll reveals that once aware of the vaccine, about two-thirds are interested in receiving it
Updated COVID-19 Vaccines Will Roll Out Mid-September, Officials Say
The new vaccines will target the XBB.1.5 coronavirus subvariant and offer some protection for closely related strains
Routine Vaccines Can Cut Risk for Later Alzheimer Disease
Findings seen for tetanus and diphtheria, shingles, and pneumococcus vaccines
FDA Approves RSV Vaccine for Pregnant Women to Help Protect Newborns
Abrysvo indicated to be given between 32 and 36 weeks of pregnancy to prevent lower respiratory tract disease caused by RSV in infants from birth through 6 months
Better Responses Seen With Booster mRNA COVID-19 Vaccine in Pregnancy
Robust immune responses found after booster dose; efficient transplacental antibody transfer was seen
Education on Approval Process May Increase Acceptance of New RSV Vaccines
Those educated on vaccine approval process or about potential severity of RSV may be more accepting
